The Clinical Management of Urologic Oncology

A special issue of Uro (ISSN 2673-4397).

Deadline for manuscript submissions: 31 December 2025 | Viewed by 51

Special Issue Editors


E-Mail
Guest Editor
Department of Urology, Humanitas Gavazzeni, 24125 Bergamo, Italy
Interests: urologic oncology; robotic surgery; prostate cancer; bladder cancer; minimally invasive surgery; surgical innovation

E-Mail Website
Guest Editor
Department of Urology, Humanitas Gavazzeni, Bergamo, Italy
Interests: bladder cancer; urothelial cancer; conservative treatment; immunotherapy; radical cystectomy; robotic surgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Urologic oncology is a rapidly evolving and multidisciplinary field, dedicated to refining clinical strategies through technological innovation, personalized approaches, and evidence-based medicine. The growing understanding of the genetic and molecular underpinnings of genitourinary tumors has led to significant advancements in diagnostic tools, therapeutic algorithms, and surgical techniques, with robotic and minimally invasive procedures now playing a central role in treatment paradigms.

This Special Issue, "The Clinical Management of Urologic Oncology", aims to provide a comprehensive overview of current standards and emerging trends in the diagnosis and treatment of urologic malignancies. Contributions will focus on prostate, bladder, kidney, and testicular cancers, highlighting novel systemic therapies, immunotherapeutic strategies, the role of molecular biomarkers, and innovations in imaging techniques.

Special attention will be devoted to the integration of precision medicine in clinical practice, the management of high-risk and advanced disease, and multidisciplinary decision-making models aimed at improving oncologic and functional outcomes. Additionally, we encourage submissions that explore the impact of therapies and clinical decisions on patients' quality of life, including functional, psychological, and social aspects, to support a more patient-centered approach to care.

By bringing together contributions from leading experts in the field, this Special Issue seeks to offer a valuable resource for urologists, oncologists, researchers, and healthcare professionals engaged in the care of patients with urologic cancers.

We hope this Special Issue will foster scientific exchange, inspire future research, and contribute to improving patient care globally.

Dr. Filippo Marino
Dr. Luca Di Gianfrancesco
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Uro is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate cancer
  • bladder cancer
  • renal cancer
  • testicular cancer
  • robotic surgery
  • genitourinary cancers
  • molecular biomarkers
  • treatment outcomes
  • quality of life

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop